Scribd
Upload
147 views4 pages

GRAFICAS

The document discusses a survey of European companies about perceived and actual incidences of economic crime. It shows that pharmaceutical companies reported fraud more than other industries, and over half of fraud cases in pharmaceuticals were discovered by accident. Companies viewed cybercrime and money laundering as the top future concerns regarding economic crime.

Uploaded by

NneiraaYoorladyyCastaño
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
147 views4 pages

GRAFICAS

The document discusses a survey of European companies about perceived and actual incidences of economic crime. It shows that pharmaceutical companies reported fraud more than other industries, and over half of fraud cases in pharmaceuticals were discovered by accident. Companies viewed cybercrime and money laundering as the top future concerns regarding economic crime.

Uploaded by

NneiraaYoorladyyCastaño
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 4

N

o
49
%

N
o
65
%

Y
es
51
%

Y
es
35
%

E
u
r
o
p
e
a
n
e
c
o
n
o
m
i
c
e
c
r
i
m
e

Regions where fraud most impacts investment decisions

No areas Americas Eastern Europe Far East and Asia

s
u
r
v
e
y

Middle East
Russia and former USSR
Western Europe
Africa

68
1%
%
8
%
3
0 %10 20 30 40 50 60 70 80 %
7
%
1
0
%
3 actual incidences of fraud
Perceived prevalence -v%

1
3
%

4%
12%

Cybercrime Money Laundering


Extortion

19%
0%
7%
6%

Corruption/Bribery
Breach of Trust Embezzlement
[Theft and
misappropriation] Tax & Excise Fraud

22%
15%
8%

Information brokerage

35%
28%

62
%
14
0% %
3
%
0%
0 10 20 30 40 50 60 70 80
% companies
Perceived prevalence of frauds
Actual incidence of frauds

Perceived non-financial damage from fraud

Brand reputation

2
0
0
1
p
h
a
r
m
a
c
e
u
t
i
c
a
l

Morale
Share price Damaged business
relationships

6223
45
%
9
%
%
%

10

20
30
40
% companies

50

s
e
c
t
o
r

How fraud is detected


Risk Management
Audit
Informants/
Tip-offs
Management Attention
Accident
Changes in management

10

20 30 40 50
% companies

60

nb: percentages total more than 100%


as respondents were able to provide multiple answers

100%

512
5
3
%
1262
%
1
%
%
%

50-99%
<50%
None
Dont know

Refused to state
0

10

20

30

40

50

% companies

Frauds considered prevalent and future concerns

Cybercrime
Money Laundering
Extortion Corruption/Bribery
Breach of Trust
Embezzlement
[Theft and
misappropriation]
Tax & Excise Fraud
Information brokerage

4
%
5%
7
%
7
% 13
%
8%

50
%

19
%

22
%
28%
28%
30
%

14
%
0%
3
%
00% 10 20 30
% companies

40

50

Perceived prevalence of frauds


Future concerns about fraud

60

Conclusion
The pharmaceutical companies surveyed were 20% more
susceptible to economic crime than other industries and over
half the cases reported were discovered by accident. With
survey respondents regarding the threat from economic crime as
likely to increase in the near future, are existing risk
management systems sufficiently robust to deter the potential
future fraudster?

Further information

The survey demographics and definitions of economic crimes can be


found in the European Economic Crime Survey 2001 report. To
download the report in pdf, visit www.pwcglobal.com/eurofraud; for
more information about our services to pharmaceuticals companies,
visit www.pwcglobal.com/pharma

You might also like